"Prepared and published under the direction of Lieutentant General Leonard D. Heaton, the Surgeon General, United States Army." ; Includes bibliographical references and index. ; Mode of access: Internet.
Progress in development of disease-modifying treatments in Parkinson's Disease Henri Huttunen, Chief Scientific Officer, Herantis Pharma Plc, charts progress in the development of disease-modifying treatments for Parkinson's disease. Recent FDA approvals of two potentially disease-modifying Alzheimer's disease drugs give hope that similar successes in Parkinson's disease may be around the corner. However, despite the recent advances in understanding complex disease biology and the development of novel drug targets and biomarkers, progress in the clinical development of new treatments remains slow.
Infections associated with international travel and outdoor activities: -- Introduction to infections associated with international travel and outdoor activities / Elaine C. Jong -- Malaria / Elaine C. Jong -- Yellow fever / Mark D. Gershman, J. Erin Staples -- Travelers' diarrhea / Martin S. Wolfe -- Enteric fever: typhoid and paratyphoid fever / Elaine C. Jong -- Viral hepatitis / Michael James Babineaux, Miriam J. Alter -- Rabies / Kis Robertson, Nina Marano, Katherine J. Johnson -- Arboviruses of medical importance / Theodore F. Tsai -- Leptospirosis / Vernon Ansdell -- Lyme disease / Christopher Sanford -- Tick-borne encephalitis / Martin Haditsch -- Primary amebic meningoencephalitis / Govinda S. Visvesvara, Jonathan S. Yoder, Michael J. Beach -- Parasitic diseases: -- Introduction to parasitic diseases / Elaine C. Jong -- Amebiasis / Martin S. Wolfe -- Giardiasis / Martin S. Wolfe -- Other intestinal protozoa / Martin S. Wolfe -- Soil-transmitted helminths and other intestinal roundworms / Elaine C. Jong -- Intestinal cestodes (tapeworms) / Douglas William MacPherson -- Cysticercosis / Raul E. Isturiz, Hector H. Garcia -- Food-borne trematodes: liver, lung, and intestinal flukes / Elaine C. Jong -- Echinococcosis: cystic and alveolar disease / Christina M. Coyle -- Trichinellosis / Zvi Shimoni, Paul Froom -- Filarial diseases / Jan Agosti -- Schistosomiasis / Elaine C. Jong -- Chagas disease / Fabiana Simão Machado, Herbert B. Tanowitz -- Emerging infectious diseases and pandemics: -- Introduction to emerging infectious diseases and pandemics / Jo Hofmann -- Novel influenza / Jo Hofmann -- Severe acute respiratory syndrome (SARS) / Eileen Schneider -- Multidrug-resistant tuberculosis / Christopher Edward Spitters -- West Nile virus disease / Grant L. Campbell ... [et al.] -- Anthrax / Benjamin D. Moser, Sean V. Shadomy, Theresa L. Smith -- Tularemia / Jo Hofmann
Zugriffsoptionen:
Die folgenden Links führen aus den jeweiligen lokalen Bibliotheken zum Volltext:
Cover -- Half Title -- Title Page -- Copyright Page -- Original Title Page -- Original Copyright Page -- Table of Contents -- Preface -- Introduction -- 1. The Problems of Undernutrition -- 2. The Problems of Food Abundance -- 3. Nutrition and Immunity -- Notes on Contributors -- Index.
Zugriffsoptionen:
Die folgenden Links führen aus den jeweiligen lokalen Bibliotheken zum Volltext:
Abstract This chapter examines the effects of religious involvement on the development of cerebrovascular disease (CBVD), on the precipitation of CBVD events such as stroke, and on the health outcomes that follow (recurrent stroke, disability, death). It begins by emphasizing that CBVD is the leading cause of serious long-term disability in later life and the second most common cause of death worldwide, second only to ischemic heart disease. It then examines risk factors for stroke and speculates how religious involvement might affect CBVD. This is followed by a review of early and more recent studies examining the relationship between religiosity and CBVD, the impact of religiosity on CBVD, and the effects of religious/spiritual interventions on CBVD. Recommendations for future research are provided, and practical applications in the clinic and the community are suggested. Religious/spiritual interventions to reverse the course of CBVD are also considered.
Tonga is an Archipelago in the south Pacific Ocean, south of Samoa. The public health brief project is on chronic diseases in Tonga. The total population of Tonga was 107,122 in 2010. The Free Wesleyan Church of Tonga is the established religion in Tonga. Tongan's make up the majority of the population but there are other ethnicities such as Euromericans and Europeans too. The major challenges faced by Tonga are decaying infrastructure, low economy, and political corruption. The widespread of non-communicable diseases such as cancer is a major health issue in Tonga. 74% of all adults in Tonga are the victim of these diseases. More than half of the total population is affected by the non-communicable diseases. There is no specific treatment available to cure non-communicable diseases. Vaccines and immunizations are ineffective against these diseases. However, certain measures can be taken to reduce the sufferings of the affected. Primary prevention should be the main aim to prevent chronic diseases. Most of the chronic diseases are incurable. Unhealthy diet, tobacco use, and physical inactivity are the essential causes of chronic diseases.